Description
Cabozantinib Tablets are potent tyrosine kinase inhibitors used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. They block tumor growth and spread by inhibiting key pathways involved in angiogenesis, metastasis, and tumor cell proliferation, improving patient outcomes significantly.